Monthly Savings
Up to $50 OFF your prescription - after your co-pay is met.
March 4, 2011 - FDA Drug Safety Communication: TOPAMAX® (topiramate) use during pregnancy can cause fetal harm, including an increased risk for cleft lip and/or cleft palate. For information from the company click here. The FDA announcement can be found at

Contact Information

We are happy to answer your questions. Thank you.
Call the Janssen Scientific Affairs, LLC. Customer Communications Center at 1-800-526-7736, 9:00 AM - 8:00 PM (ET), Monday through Friday, Saturday and Sunday 9:00 AM - 5:00 PM (ET).